Lyra Therapeutics Statistics
Total Valuation
LYRA has a market cap or net worth of $7.58 million. The enterprise value is $16.90 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LYRA has 1.77 million shares outstanding. The number of shares has increased by 12.03% in one year.
| Current Share Class | 1.77M |
| Shares Outstanding | 1.77M |
| Shares Change (YoY) | +12.03% |
| Shares Change (QoQ) | +31.08% |
| Owned by Insiders (%) | 1.29% |
| Owned by Institutions (%) | 6.23% |
| Float | 1.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.22 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 28.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.43
| Current Ratio | 2.43 |
| Quick Ratio | 2.33 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -404.48% and return on invested capital (ROIC) is -48.81%.
| Return on Equity (ROE) | -404.48% |
| Return on Assets (ROA) | -33.08% |
| Return on Invested Capital (ROIC) | -48.81% |
| Return on Capital Employed (ROCE) | -94.68% |
| Revenue Per Employee | $20,000 |
| Profits Per Employee | -$1.10M |
| Employee Count | 30 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LYRA has paid $15,000 in taxes.
| Income Tax | 15,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.91% in the last 52 weeks. The beta is -0.01, so LYRA's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | -59.91% |
| 50-Day Moving Average | 5.51 |
| 200-Day Moving Average | 7.40 |
| Relative Strength Index (RSI) | 48.30 |
| Average Volume (20 Days) | 94,840 |
Short Selling Information
The latest short interest is 46,498, so 2.62% of the outstanding shares have been sold short.
| Short Interest | 46,498 |
| Short Previous Month | 23,373 |
| Short % of Shares Out | 2.62% |
| Short % of Float | 3.09% |
| Short Ratio (days to cover) | 1.45 |
Income Statement
In the last 12 months, LYRA had revenue of $600,000 and -$32.95 million in losses. Loss per share was -$22.93.
| Revenue | 600,000 |
| Gross Profit | -19.80M |
| Operating Income | -32.41M |
| Pretax Income | -32.93M |
| Net Income | -32.95M |
| EBITDA | -31.90M |
| EBIT | -32.41M |
| Loss Per Share | -$22.93 |
Full Income StatementBalance Sheet
The company has $22.06 million in cash and $31.38 million in debt, giving a net cash position of -$9.32 million or -$5.25 per share.
| Cash & Cash Equivalents | 22.06M |
| Total Debt | 31.38M |
| Net Cash | -9.32M |
| Net Cash Per Share | -$5.25 |
| Equity (Book Value) | -4.33M |
| Book Value Per Share | -2.63 |
| Working Capital | 13.54M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$34.15 million and capital expenditures $38,000, giving a free cash flow of -$34.11 million.
| Operating Cash Flow | -34.15M |
| Capital Expenditures | 38,000 |
| Free Cash Flow | -34.11M |
| FCF Per Share | -$19.22 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -5,401.33% |
| Pretax Margin | -5,488.67% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LYRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.03% |
| Shareholder Yield | -12.03% |
| Earnings Yield | -434.73% |
| FCF Yield | -450.03% |
Analyst Forecast
The average price target for LYRA is $16.00, which is 274.71% higher than the current price. The consensus rating is "Hold".
| Price Target | $16.00 |
| Price Target Difference | 274.71% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 98.78% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 28, 2025. It was a reverse split with a ratio of 1:50.
| Last Split Date | May 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
LYRA has an Altman Z-Score of -15.58. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.58 |
| Piotroski F-Score | n/a |